期刊文献+

肺癌患者血浆纤维蛋白原、D-二聚体、抗凝血酶Ⅲ水平变化及意义 被引量:15

下载PDF
导出
摘要 目的观察肺癌患者血浆纤维蛋白原(FIB)、D-二聚体及抗凝血酶Ⅲ(AT-Ⅲ)水平变化,并探其临床意义。方法采用STAGO STA-Compact全自动凝血仪检测65例肺癌(观察组)、50例健康体检者(对照组)血浆中的FIB、D-二聚体、AT-Ⅲ。结果观察组血浆FIB与D-二聚体水平均明显高于对照组(P均<0.01),而AT-Ⅲ活性低于对照组(P<0.01)。血浆FIB、D-二聚体、AT-Ⅲ水平与肺癌患者TNM分期及淋巴结转移有关(P均<0.05)。结论肺癌患者血浆FIB、D-二聚体水平均升高、AT-Ⅲ活性降低,凝血及纤溶的异常在肺癌的发生、发展中起重要作用。
机构地区 济南军区总医院
出处 《山东医药》 CAS 2012年第18期44-45,共2页 Shandong Medical Journal
  • 相关文献

参考文献8

  • 1Mousa SA. Role of current and emerging antithmmbotics in thrombo- sis and cancer[J]. Drugs Today(Bare), 2006,42(5) :331-350.
  • 2Falanga A, Panova-Noeva M, Russo L. procoagulant mechanisms in tumour cells[J]. Best Pract Res Clin Haematol, 2009,22(1 ) :49- 60.
  • 3Schoenleber SJ, Knrtz DM, Talwalkar JA, et al. Prognostic role of vascular endothelial growth factor in hepatocenular carcinoma: sys- tematic review and meta-analysis[ J]. Br J Cancer, 2009,100(9) : 1385-1392.
  • 4Kreisl TN, Toothaker T, Karimi S, et al. Isehemic stroke in patients with primary brain tumors [ J ]. Neurology, 2008,70 ( 24 ) : 2314- 2320.
  • 5Chorostowska-Wynimko J, Swiercz R, Skrzypczak-Jankun E, et al. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells [ J ]. Oncol Rep, 2004,12(6) :1155-6112.
  • 6Unsal E, Atalay F, Atikcan S, et al. Prognostic significance of he- mostatic parameters in patients with lung cancer[ J ]. Respir Med, 2004,98 (2) :93-98.
  • 7Weitz IC, Israel VK, Waisman JR, et al. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium ) on plasma markers of hemostatic activation [J]. Thromb Haemost, 2002,88(2):213-220.
  • 8Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: incidence and etiology [ J ]. Neurology, 2004,62 ( 11 ) : 2025 -2030.

同被引文献138

引证文献15

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部